News
Welcome Bioreme
We are thrilled to welcome BIOREME (Integrating data-driven BIOphysical models into REspiratory MEdicine), a pioneering collaborative network based in the UK, as Avicenna new Partner!
Virtual launch of "Toward Good Simulation Practice" book
On May 8, 2024, the virtual launch of "Toward Good Simulation Practice: Best Practices for the Use of Computational Modeling and Simulation (CM&S) in the Regulatory Process of Biomedical Products" took place, marking a significant milestone in regulatory science and industry.
Appointment of Avicenna Formal Administrators
At its recent General Assembly, the members of the Avicenna Alliance have confirmed that three members of the Avicenna Board will act as legal representatives of the Avicenna Alliance. As a Belgian non-profit organisation, the Avicenna Alliance allocate the following positions:
Avicenna at FDA / MDIC Event in Washington, April 16 - 17
Many representatives of the Avicenna Alliance networked with good friends and in silico thought leaders from around the world at the FDA / MDIC symposium on Computation Modeling & Simulation in Washington.
The European Parliament voted the reform of General Pharmaceutical Legislation (GPL)
On April 10, the European Parliament overwhelmingly backed the reform of General Pharmaceutical Legislation (GPL), marking a pivotal moment in healthcare regulation. With a resounding majority, both the Directive and Regulation were embraced, reflecting a collaborative effort within the ENVI committee.
The Avicenna Alliance warmly welcomes Tox By Design into its esteemed ranks!
Tox by Design is a prominent European toxicological expertise firm specializing in conducting toxicological Risk Assessments (RAs) for various industries such as biotech, pharmaceuticals, cosmetics, medical devices, and API synthesis.
